Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells.
Saved in:
| Title: | Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells. |
|---|---|
| Authors: | Fiskus W; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Manshouri T; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Birdwell C; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Mill CP; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Masarova L; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Bose P; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kadia TM; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Daver N; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., DiNardo CD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Borthakur G; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Khoury JD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Verstovsek S; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Bhalla KN; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. kbhalla@mdanderson.org. |
| Source: | Blood cancer journal [Blood Cancer J] 2022 Jan 31; Vol. 12 (1), pp. 23. Date of Electronic Publication: 2022 Jan 31. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-022-00618-4 |
